Zimmer Biomet (ZBH) revenue breakdown
By product, Knees is the largest at 40% of fiscal 2025 revenue; Technology & Data, Bone Cement and Surgical grew fastest, 8% a year over 9 years.
By region, Americas is the largest at 62% of fiscal 2025 revenue; EMEA grew fastest, 8% a year over 3 years.
Revenue by product
Fiscal years, as Zimmer Biomet reports them in its 10-K filings; fiscal 2025 total $8.2B.
| Products | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Knees | $2.8B | $2.7B | $2.8B | $2.8B | $2.4B | $2.6B | $2.8B | $3.0B | $3.2B | $3.3B | 40% |
| S.E.T | $1.6B | $1.7B | $1.4B | $1.7B | $1.5B | $1.7B | $1.7B | $1.8B | $1.9B | $2.2B | 26% |
| Hips | $1.9B | $1.9B | $1.9B | $1.9B | $1.8B | $1.9B | $1.9B | $2.0B | $2.0B | $2.1B | 25% |
| Technology & Data, Bone Cement and Surgical | $328M | $319M | $664M | $596M | $473M | $596M | $570M | $636M | $640M | $666M | 8% |
| Spine & Dental | — | — | $1.2B | $1.0B | — | — | — | — | — | — | — |
| Spine and CMF | $661M | $758M | — | — | — | — | — | — | — | — | — |
| Dental | $428M | $419M | — | — | — | — | — | — | — | — | — |
Revenue by region
Fiscal years, as Zimmer Biomet reports them in its 10-K filings; fiscal 2025 total $8.2B.
| Regions | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas | — | — | — | — | — | — | $4.3B | $4.6B | $4.8B | $5.1B | 62% |
| EMEA | — | — | — | — | — | — | $1.5B | $1.6B | $1.7B | $1.8B | 22% |
| Asia Pacific | — | — | — | — | — | — | $1.2B | $1.2B | $1.2B | $1.3B | 15% |
| Americas | $3.9B | $3.9B | $4.8B | $4.9B | — | — | — | — | — | — | — |
| United States | — | — | — | — | $3.5B | $3.9B | — | — | — | — | — |
| International | — | — | — | — | $2.6B | $3.0B | — | — | — | — | — |
| EMEA | $1.5B | $1.5B | $1.8B | $1.7B | — | — | — | — | — | — | — |
| Asia Pacific | $1.1B | $1.2B | $1.3B | $1.4B | — | — | — | — | — | — | — |
| Immaterial Product Category Operating Segments | $1.1B | $1.2B | — | — | — | — | — | — | — | — | — |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for ZBH.
Open ZBH in InvestinglyQuestions
Where does Zimmer Biomet make its money?
In fiscal 2025, by product: Knees $3.3B, S.E.T $2.2B, Hips $2.1B, Technology & Data, Bone Cement and Surgical $666M.
From Zimmer Biomet's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.